ALXN
Sands Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,766,636
| Closed | -$269M | – | 75 |
|
|
2018
Q4 | $269M | Sell |
2,766,636
-198,591
| -7% | -$19.3M | 0.96% | 33 |
|
|
2018
Q3 | $412M | Sell |
2,965,227
-259,112
| -8% | -$36M | 1.17% | 27 |
|
|
2018
Q2 | $400M | Sell |
3,224,339
-217,269
| -6% | -$27M | 1.15% | 29 |
|
|
2018
Q1 | $384M | Sell |
3,441,608
-1,111,487
| -24% | -$124M | 1.13% | 30 |
|
|
2017
Q4 | $545M | Sell |
4,553,095
-222,852
| -5% | -$26.7M | 1.65% | 23 |
|
|
2017
Q3 | $670M | Sell |
4,775,947
-1,570,127
| -25% | -$220M | 2.01% | 18 |
|
|
2017
Q2 | $772M | Buy |
6,346,074
+1,110,444
| +21% | +$135M | 2.32% | 17 |
|
|
2017
Q1 | $635M | Sell |
5,235,630
-349,638
| -6% | -$42.4M | 1.99% | 19 |
|
|
2016
Q4 | $683M | Buy |
5,585,268
+339,516
| +6% | +$41.5M | 2.38% | 17 |
|
|
2016
Q3 | $643M | Buy |
5,245,752
+370,994
| +8% | +$45.5M | 1.89% | 22 |
|
|
2016
Q2 | $569M | Sell |
4,874,758
-337,121
| -6% | -$39.4M | 1.76% | 23 |
|
|
2016
Q1 | $726M | Sell |
5,211,879
-844,883
| -14% | -$118M | 2.14% | 21 |
|
|
2015
Q4 | $1.16B | Sell |
6,056,762
-323,095
| -5% | -$61.6M | 2.98% | 15 |
|
|
2015
Q3 | $998M | Sell |
6,379,857
-139,689
| -2% | -$21.8M | 2.79% | 16 |
|
|
2015
Q2 | $1.18B | Buy |
6,519,546
+1,315,250
| +25% | +$238M | 2.9% | 16 |
|
|
2015
Q1 | $902M | Sell |
5,204,296
-63,607
| -1% | -$11M | 2.15% | 22 |
|
|
2014
Q4 | $975M | Sell |
5,267,903
-43,585
| -0.8% | -$8.06M | 2.32% | 20 |
|
|
2014
Q3 | $881M | Buy |
5,311,488
+31,706
| +0.6% | +$5.26M | 2.19% | 21 |
|
|
2014
Q2 | $825M | Buy |
5,279,782
+11,364
| +0.2% | +$1.78M | 2.08% | 23 |
|
|
2014
Q1 | $801M | Sell |
5,268,418
-2,102,183
| -29% | -$320M | 2.09% | 24 |
|
|
2013
Q4 | $979M | Sell |
7,370,601
-169,804
| -2% | -$22.6M | 2.56% | 20 |
|
|
2013
Q3 | $876M | Sell |
7,540,405
-884,162
| -10% | -$103M | 2.44% | 19 |
|
|
2013
Q2 | $777M | Buy |
+8,424,567
| New | +$777M | 2.62% | 18 |
|